Literatur
-
01
Brande A A (ed.).
The second international conference on future trends in the treatment of brain tumors.
Sem. Oncol..
2003;
30
(S 19)
-
02
Buckner J C (ed.).
Brain tumors.
Sem Oncol.
2004;
31
593-713
-
03
Chang S M, Theodosopoulos P, Lamborn K. et al .
Temozolomide in the treatment of recurrent malignant gliomas.
Cancer.
2004;
100
605-611
-
04
Glantz M, Chamberlain M, Liu Q. et al .
Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas.
Cancer.
2003;
97
2262-2266
-
05
Hager E D, Dziambor H. et al .
The treatment of patients with high-grade malignant gliomas with RF-hyperthermia.
Proceedings of ASCO.
2003;
470
-
06
Jordan A, Scholz R, Maier-Hauff K. et al .
Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia.
J. of Magnetism and Magnetic Materials.
2001;
225
118-126
-
07
Kapelle A C, Postma T J, Taphoorn M J. et al .
PCV chemotherapy for recurrent glioblastoma multiforme.
Neurology.
2001;
56
118-120
-
08
Kortmann R D, Becker G, Kühl J. et al .
Strahlentherapie bei malignen Gliomen.
Onkologe.
1998;
4
608-617
-
09
Nieder C, Grosu A L, Molls M.
A comparison of treatment results for recurrent malignant gliomas.
Cancer Treat.
2000;
26
397-409
-
10
Ohno T, Wakabayashi T, Takemura A. et al .
Effective solitary hyperthermia treatment of malignant glioma using stick type CMC-magnetite. In vivo study.
J. Neurooncology.
2002;
56
(3)
233-239
-
11
Osoba D, Brada M, Yung. et al .
Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme.
J. Clin. Oncol..
2000;
18
1481-1491
-
12
Stupp R, Mason W P, Bent M J van den. et al .
Radiotherapie plus concomitant and adjuvant temozolamide for glioblastoma.
N. Engl. J. Med..
2005;
352
987-996
-
13
Walker M D, Strike T A, Sheline S E.
An analysis of dose-effect relationship of malignant gliomas.
Int. J. Radiat. Oncol. Biol. Phys..
1979;
5
1725-1731
-
14 Weller M. Intersisziplinäre S2-Leitline für die Diagnostik und Therapie der Gliome des Erwachsenenalters. Deutsche Krebsgesellschaft München; W. Zuckschwerdt Verlag 2004
-
15
Wiestler O D, Schmidt M C.
Neuropathologie maligner Gliome.
Onkologe.
1998;
4
580-588
Korrespondenzadresse
Dr. med. Jürgen Birkenmeier
Chefarzt
BioMed-Klinik Betriebs GmbH
Tischberger Str. 5 + 8
76887 Bad Bergzabern
Email: medinfo@biomed-klinik.de
